SCHEMBL6946072

SCHEMBL6946072

CCOC(=O)Nc1cc(F)ccc1C#N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.55
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
ALDH1A1 P00352 3/20 0.49
GAA P10253 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
KCNQ2 O43526 4/20 0.46
KCNQ3 O43525 3/20 0.46
KCNQ4 P56696 2/20 0.46
POLB P06746 2/20 0.46
KCNQ5 Q9NR82 1/20 0.46
MAPT P10636 3/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
ABCB11 O95342 1/20 0.44
ESR1 P03372 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988070 0.89 NLRP3 (0.55) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL7505227 0.87 CYP1A2 (0.67) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL404741 0.85 POLB (0.44) NLRP3ALDH1A1GAASMN1; SMN2KCNQ2
SCHEMBL7503320 0.84 NLRP3 (0.56) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL29649018 0.83 NLRP3 (0.55) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL6949339 0.83 NLRP3 (0.55) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL22987921 0.83 NLRP3 (0.55) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL404508 0.83 NLRP3 (0.51) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL7507035 0.83 NLRP3 (0.52) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL22987487 0.82 NLRP3 (0.54) NLRP3CYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985666-B1 Substituted indole compounds as COX-2 inhibitors PFIZER (US) 2003-11-05 EP disclosed
EP-1001934-B1 INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2002-11-27 EP disclosed
US-6300363-B1 USEFUL IN THE TREATMENT OR ALLEVIATION OF INFLAMMATION AND OTHER INFLAMMATION ASSOCIATED DISORDERS IN MAMMALS PFIZER INC. 2001-10-09 US disclosed
US-6277878-B1 ANTIINFLAMMATORY AGENTS; ANALGESICS PFIZER INC 2001-08-21 US disclosed
EP-1001934-A1 INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 2000-05-24 EP disclosed
EP-0985666-A1 Substituted indole compounds as COX-2 inhibitors PFIZER INC. (US) 2000-03-15 EP disclosed
WO-1999005104-A1 INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-02-04 WO disclosed